Medications

Counterfeit medicine trade targets Africa's poor

From Cameroon to Ivory Coast, Kenya to the DR Congo, traders in counterfeit drugs do a thriving business with the utmost cynicism and sometimes at the cost of human lives.

Diseases, Conditions, Syndromes

Rivaroxaban found noninferior to enoxaparin in acutely ill

(HealthDay)—In acutely ill hospitalized patients, standard-duration rivaroxaban has similar efficacy as enoxaparin in reducing the risk of venous thromboembolism, while extended-duration rivaroxaban has superior efficacy, ...

Other

Valeant to buy Bausch + Lomb for $8.7B (Update)

Canadian drugmaker Valeant Pharmaceuticals said Monday that it will pay $8.7 billion to buy Bausch + Lomb, one of the world's best-known makers of contact lenses, in a massive expansion of Valeant's smaller ophthalmology ...

Medications

Q&A: The legal drug crisis in the US

Three out of four American adults say prescription drug prices are unaffordable, and nearly a third admit to not taking prescribed medications due to cost, according to a recent poll conducted by the Kaiser Family Foundation. ...

Health

Cigarette co Reynolds taking nicotine gum national

Cigarette maker Reynolds American Inc. is taking its Zonnic brand nicotine gum nationwide, challenging the pharmaceutical industry's hold and pricing power of the market for products to help people stop smoking.

Medical economics

Pfizer and Moderna won't be the only ones to reap huge payday

Pfizer and Moderna appear to be the clear leaders in the race for a COVID-19 vaccine. Pfizer has already begun distribution, and Moderna's entry is on the brink of FDA approval, which would put the two at least weeks ahead ...

page 4 from 5